Opinion statement
When treating soft tissue sarcomas (STS) of the extremities, the major therapeutic goals are survival, local tumor control, optimal function, and minimal morbidity. Surgical resection of the primary tumor is the essential component of treatment for virtually all patients. However, local control by surgery alone is poor for the majority of patients with extremity lesions unless the procedure removes large volumes of grossly normal tissue (ie, widely negative margins are attained, because sarcomas tend to infiltrate normal tissue adjacent to the evident lesion). Thus, removal of the gross lesion by a simple excision alone is followed by local recurrence in 60% to 90% of patients. Radical resections reduce the local recurrence rate to 10% to 30%, but may compromise limb function. The combination of function-sparing surgery and radiation achieves better outcomes than either treatment alone for nearly all patients with STS. Because both surgical and radiation technique are critically important for optimizing local control of tumor and functional outcome, it is important to manage these patients in dedicated multispecialty clinics comprised of physicians with expertise in sarcomas, including orthopedic and general oncologic surgeons, radiation oncologists, medical oncologists, sarcoma pathologists, and bone and soft tissue diagnostic radiologists. Radiation therapy can be given by external beam radiation therapy (EBRT) or brachytherapy (BRT) or combination thereof. External beam radiation can be given either preoperatively or postoperatively. The clinical considerations and the outcome data that must be considered in choosing the most appropriate treatment technique for the individual patient are discussed.
Similar content being viewed by others
References and Recommended Reading
Jemal A, Tiwari RC, Murray T, et al.: Cancer statistics, 2004. CA Cancer J Clin 2004, 54:8–29.
Markhede G, Angervall L, Stener B: A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 1982,49:1721–1733.
Simon MA, Enneking WF: The management of softtissue sarcomas of the extremities. J Bone Joint Surg Am 1976, 58:317–327.
Rosenberg SA, Tepper J, Glatstein E, et al.: The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of: 1) limb-sparing surgery plus radiation therapy compared with amputation, and 2) the role of adjuvant chemotherapy. Ann Surg 1982, 196:305–315.
Suit HD, Russell WO, Martin RG: Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer 1975, 35:1478–1483.
Lindberg RD, Martin RG, Romsdahl MM, Barkley HT, Jr: Conservative surgery and postoperative radiotherapy in 300 adults with soft tissue sarcomas. Cancer 1981, 47:2391–2397.
Potter DA, Glenn J, Kinsella T, et al.: Patterns of recurrence in patients with high-grade soft tissue sarcomas. J Clin Oncol 1985, 3:353–366.
DeLaney TF, Rosenberg AE, Harmon DC, et al.: Soft tissue sarcomas. In Price PM, Edited by Sikora K. Treatment of Cancer, 4th ed. London. Arnold. 2003, 869–907.
Brant TA, Parsons JT, Marcus RB, et al.: Preoperative irradiation for soft tissue sarcomas of the trunk and extremities in adults. Int J Radiat Oncol Biol Phys 1990, 19:899–906.
Karakousis CP, Emrich LJ, Rao U, Krishnamsetty RM: Feasibility of limb salvage and survival in soft tissue sarcomas. Cancer 1986, 57:484–491.
Harrison LB, Franzese F, Gaynor JJ, Brennan MF: Longterm results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 1993, 27:259–265.
Eilber FC, Rosen G, Nelson SD, et al.: High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 2003, 237(2):218–226. Local recurrence in patients with intermediate-to high-gradeextremity soft tissue sarcomas is associated with the development of subsequent local recurrences, a morbid event decreasing functional outcomes, and the most significant factor associated with decreased survival.
Williard WC, Hajdu SI, Casper ES, Brennan MF: Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity269. Ann Surg 1992, 215:389–396.
LeVay J, O’Sullivan B, Catton C, et al.: Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys 1993, 27:1091–1090.
Karakousis CP, Driscoll DL: Treatment and local control of primary extremity soft tissue sarcomas. J Surg Oncol 1999, 71:155–161.
Sadoski C, Suit HD, Rosenberg A, et al.: Pre-operative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol 1993, 52:223–230.
Tanabe KK, Pollock RE, Ellis LM, et al.: Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer 1994, 73:1652–1659.
Pisters PW, Leung DH, Woodruff J, et al.: Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996, 14:1679–1689.
Trovik CS, Bauer HC, Alvegard TA, et al.: Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000, 36:710–716. Local recurrence was associated with an increased risk of metastasis.
Zagars GK, Ballo MT, Pisters PW, et al.: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer 2003, 97:2530–2543. Prognostic factors for local recurrence, disease-specific survival, and overall survival are examined in a large series of patients with soft-tissue sarcoma treated with conservative surgery and radiation.
Alvegard TA, Sigurdsson H, Mouridsen H, et al.: Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989, 7:1504–1513. decreasing.
Eilber FR, Eckardt J: Surgical management of soft tissue sarcomas. Semin Oncol 1997, 24:526–533.
Noria S, Davis A, Kandel R, et al.: Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am 1996, 78:650–655.
Rydholm A, Gustafson P, Rooser B, et al.: Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 1991, 9:1757–1765.
Baldini EH, Goldberg J, Jenner C, et al.: Long-term outcomes after functon-sparing surgery without radiotherapy for soft tissue sarcoma of the extemities and trunk. J Clin Oncol 1999, 17:3252–3259.
Ruka W, Taghian A, Gioioso D, et al.: Comparison between the in vitro intrinsic radiation sensitivity of human soft tissue sarcoma and breast cancer cell lines. J Surg Oncol 1996, 61:290–294.
Tepper JE, Suit HD: Radiation therapy alone for sarcoma of soft tissue. Cancer 1985, 56:475–479.
Todoroki T, Suit HD: Therapeutic advantage in preoperative single-dose radiation combined with conservative and radical surgery in different-size murine fibrosarcomas. J Surg Oncol 1985, 29:207–215.
Yang JC, Chang AE, Baker AR, et al.: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998, 16:197–203.
O’Sullivan B, Davis A, Bell R, et al.: Phase III randomized trial of pre-operative versus post operative radiotherapy in the curative management of extremity soft tissue sarcoma. A Canadian Sarcoma Group and NCI Canada Clinical Trials Group study. Proc ASCO 1999, 18:2066A.
O’Sullivan B, Davis AM, Turcotte R, et al.: Five-year results of a randomized phase III trial of pre-operative versus postoperative radiotherapy in extremity soft tissue sarcoma. Proc Am Soc Clin Oncol 2004, 23:815. Postoperative radiation therapy results in more late, often irreversible, grade-2 to -4 complications, including fibrosis than pre-operative radiotherapy.
Pisters PW, Harrison LB, Leung DH, et al.: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996, 14:859–868.
Alektiar KM, Zelefsky MJ, Brennan MF: Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 2000, 47:1273–1279. Brachytherapy and width of excised skin greater than 4 cm were associated with significantly higher wound re-operation rate.
Panchal JI, Agrawal RK, McLean NR, Dawes PJ: Early postoperative brachytherapy, and free-flap reconstruction in the management of sarcomas. Euro J Surg Oncol 1996, 22:144–146.
Niewald M, Berberich W, Schnabel K, et al.: A simple method for positioning and fixing the extremities during the radiotherapy of soft-tissue sarcomas. Strahlenther Onkol 1990, 166:295–296.
Tepper J, Rosenberg SA, Glatstein E: Radiation therapy technique in soft tissue sarcomas of the extremity—policies of treatment at the National Cancer Institute. Int J Radiat Oncol Biol Phys 1982, 8:263–273.
Suit HD: Treatment of the patient with stage M0 sarcoma of soft tissue. J Clin Oncol 1988, 6:854–862.
Zagars GK, Ballo MT: Significance of dose in post operative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2003, 56:473–481.
Chan MF, Chui CS, Schupak K, et al.: The treatment of large extraskeletal chondrosarcoma of the leg: comparison of IMRT and conformal radiotherapy techniques. J Appl Clin Med Phys 2001, 2:3–8.
Hong L, Alektiar KM, Hunt M, et al.: Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys 2004, 59:752–759. Intensity modulated radiotherapy plans allow for selective sparing of femur and selected soft tissue in the extremity; further clinical experience is needed.
Lee N, Chuang C, Quivey JM, et al.: Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2002, 53:630–637.
Eilber FC, Rosen G, Eckardt J, et al.: Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001, 19:3203–3209.
Wanebo HJ, Temple WJ, Popp MB, et al.: Pre-operative regional therapy for extremity sarcoma: a tricenter update. Cancer 1995, 75:2299–2306.
Eilber F, Eckardt J, Rosen G, et al.: Pre-operative therapy for soft tissue sarcoma. Hematol Oncol Clin North Am 1995, 9:817–823.
DeLaney TF, Spiro IJ, Suit HD, et al.: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2003, 56:1117–1127. Neoadjuvant chemoradiation resulted in high rates of local and systemic control in this pilot study.
Kraybill WG, Spiro I, Harris J, et al.: Radiation Therapy Oncology Group (RTOG) 95–14: A phase II study of neoadjuvant chemotherapy (CT) and radiation therapy (RT) in high risk (HR), high grade, soft tissue sarcomas (STS) of the extremities and body wall: a preliminary report. Proc ASCO 2001, 20:348a.
Talbert ML, Zagars GK, Sherman NE, Romsdahl MM: Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ankle, and foot. Cancer 1990, 66:2482–2491.
Johnstone PAS, Wexler LH, Venzon DJ, et al.: Sarcomas of the hand and foot: analysis of local control and functional result with combined modality therapy in extremity preservation. Int J Radiat Oncol Biol Phys 1994, 29:735–745.
Karakousis CP, De Young C, Driscoll DL: Soft tissue sarcomas of the hand and foot: management and survival. Ann Surg Oncol 1998, 5:238–240.
Bujko K, Suit HD, Springfield DS, Convery K: Wound healing after surgery and pre-operative radiation for sarcoma of soft tissues. Surg Gynecol Obstet 1992, 176:124–134.
Arbeit JM, Hilaris B, Brennan MF: Wound complications in the multimodality treatment of extremity and superficial truncal sarcomas. J Clin Oncol 1987, 5:480–488.
Robinson MH, Spruce L, Eeles R, et al.: Limb function following conservation treatment of adult soft tissue sarcoma. Eur J Cancer 1991, 27:1567–1574.
Stinson SF, DeLaney TF, Greenberg J, et al.: Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1991, 21:1493–1499.
Davis AM, Devlin M, Griffin AM, et al.: Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study. Arch Phys Med Rehabil 1999, 80:615–618.
Gerrand CH, Wunder JS, Kandel RA, et al.: The influence of anatomic location on functional outcome in lower-extremity soft tissue sarcoma. Ann Surg Oncol 2004, 11:476–482. The treatment of superficial tumors did not lead to a significant decrease in functional outcome scores.
Catton C, Davis A, Bell R, et al.: Soft tissue sarcoma of the extremity; limb salvage after failure of combined conservative therapy. Radiother Oncol 1996, 41:209–214.
Karakousis CP, Proimakis C, Rao U, et al.: Local recurrence and survival in soft tissue sarcomas. Ann Surg Oncol 1996, 3:255–260.
Ueda T, Yoshikawa H, Mori S, et al.: Influence of local recurrence on the prognosis of soft tissue sarcomas. J Bone Joint Surg Br 1997, 79:553–557.
Pearlstone DB, Janjan NA, Feig BW, et al.: Reresection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am 1999, 5:26–33.
Lejeune FJ, Pujol N, Lienard D, et al.: Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Eur J Surg Oncol 2000, 26:669–678.
Pickering DG, Stewart JS, Rampling R, et al.: Fast neutron therapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1987, 13:1489–1495.
Schmitt G, Pape H, Zamboglou N: Long-term results of neutron-and neutron-boost irradiation of soft tissue sarcomas. Strahlenther Onkol 1990, 166:61–62.
Steingraber M, Lessel A, Jahn U: Fast neutron therapy in treatment of soft tissue sarcoma—the Berlin-Buch study. Bull Cancer Radiother 1996, 83(Suppl):122–124.
Goffman T, Tochner Z, Glatstein E: Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation. Cancer 1991, 67:572–576.
Rhomberg W, Hassenstein EO, Gefeller D: Radiotherapy versus radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study. Int J Radiat Oncol Biol Phys 1996, 36:1077–1084.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeLaney, T.F. Optimizing radiation therapy and post-treatment function in the management of extremity soft tissue sarcoma. Curr. Treat. Options in Oncol. 5, 463–476 (2004). https://doi.org/10.1007/s11864-004-0035-1
Issue Date:
DOI: https://doi.org/10.1007/s11864-004-0035-1